Related Experiment Videos
Performance characteristics of a commercial ECG gate
Summary
A commercial electrocardiogram (ECG) gate accurately predicts end-systole timing, aligning with manufacturer specs. This timing is crucial for reliable left-ventricular ejection fraction calculations in cardiac imaging.
Area of Science:
- Cardiology
- Nuclear Medicine
- Biomedical Engineering
Background:
- Accurate determination of end-systole is vital for cardiac function assessment.
- Existing methods for end-systole timing can be complex or computationally intensive.
Purpose of the Study:
- To evaluate the accuracy of a commercial ECG gate in predicting end-systole timing.
- To assess the impact of using predicted end-systole times on left-ventricular ejection fraction (LVEF) calculations.
Main Methods:
- A commercial ECG gate was used to predict end-systole times.
- Predicted end-systole times were compared against actual times derived from computer-analyzed left-ventricular time-activity curves.
- Time-activity curves were generated using Technetium-99m-labeled red blood cells (Tc-99m RBCs).
Main Results:
- The ECG gate's predicted end-systole times closely matched manufacturer specifications.
- A significant correlation (r = 0.829, n = 59) was observed between predicted and actual end-systole times, despite moderate scatter.
- Calculating LVEF using predicted end-systole times resulted in an error of 0.03 or less for 95% of subjects.
Conclusions:
- The commercial ECG gate provides a reliable method for predicting end-systole timing in cardiac studies.
- The accuracy of this device supports its use in clinical settings for improving LVEF assessment.
- This technology offers a practical approach to enhance the precision of cardiac function measurements using nuclear imaging.